Medable raises $304 million

Palo Alto-based patient-focused clinical research platform Medable has closed its fourth fundraise since 2020 - a $304 million Series D round of venture funding at a $2.1 billion valuation. The latest deal was co-led by new investors Blackstone Growth and Tiger Global and existing investor GSR Ventures.

Founded in 2012, Medable has raised almost $500 million to date and has grown 300% in the past year and over 800% in the last 18 months. The company’s software is currently being used in 150 clinical trials across 5,000 clinical sites in 60 countries.